At #ASCO24, our #oncology team will be onsite showcasing our expanding solid tumor research and commitment to transforming cancer care. Stop by booth 23093 to learn more.
AbbVie
Fabricación de productos farmacéuticos
North Chicago, Illinois 1.362.866 seguidores
Sobre nosotros
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employs approximately 26,000+ people worldwide and markets medicines in more than 170+ countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter and like us on Facebook.
- Sitio web
-
http://www.abbvie.com
Enlace externo para AbbVie
- Sector
- Fabricación de productos farmacéuticos
- Tamaño de la empresa
- Más de 10.001 empleados
- Sede
- North Chicago, Illinois
- Tipo
- Empresa pública
- Especialidades
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics y Eye Care
Ubicaciones
Empleados en AbbVie
Actualizaciones
-
NEWS: The European Medicines Agency's #CHMP granted a positive opinion for our investigational treatment in #UlcerativeColitis. Read more: https://bit.ly/4bDSiUJ #IBD [Video description: On-screen text reads, “Immunology News. Positive CHMP Opinion in Ulcerative Colitis.”]
-
Attending #ASCO24? Meet with our team of experts working to transform the standards of care for #cancer patients. Explore our career opportunities in #oncology: https://bit.ly/4bZsAtG
-
Over the past decade, new approaches and innovation have enabled scientists to reimagine #BloodCancer research – but there's more to discover. See why our scientists won’t settle when it comes to treating #cancer. https://bit.ly/3V2ggSv #WorldBloodCancerDay
-
JUST IN: We’re presenting three oral abstracts at #ASCO24 highlighting new data from our #ADC platform in #SolidTumors with high unmet needs. Read more: https://bit.ly/4bS231q [Video description: On-screen text reads, “Oncology News.”]
-
Landos Biopharma, Inc. is now part of AbbVie. This #acquisition expands our #IBD pipeline and advances our commitment to make a real difference in people’s lives. Learn more: https://bit.ly/3RlEFSn $ABBV [Video description: On-screen text reads, “Landos is now part of AbbVie" followed by the AbbVie and Landos logos.]
-
Supriya Nair, global co-chair of our Asian Leadership Network employee resource group, shares how our culture inspires her to be her most authentic self. See the difference you can make – join us: https://lnkd.in/e_RW34f7 #AAPIHM #AbbVieLife [Image description: Supriya Nair, Associate Director, Field Tools, AbbVie, says “AbbVie encourages me to be myself by fostering an environment of belonging and psychological safety, empowering me to make a positive impact through innovation, inclusiveness and authenticity.”]
-
Today marks the start of our summer #intern program. As we welcome this year’s group, hear some of our development program members’ advice for our 250+ incoming students, representing 92 universities from 30 states, supporting teams in R&D, commercial, operations and more. #AbbVieLife [Video description: Five AbbVie development program members answer the question, “What advice would you give our 2024 summer interns?”]
-
To truly understand how medications will work for people of different races, ethnicities, genders and backgrounds, #ClinicalTrials need greater diversity. Explore the bold actions we’re taking to drive greater inclusion and engage patients, caregivers and physicians in the process: https://bit.ly/4bG4u72 #ClinicalTrialsDay
-
On #ClinicalTrialsDay, we’re grateful for the researchers, investigators and patients who make our #ClinicalTrials possible. Thank you for supporting our efforts to discover future treatments and cures. Learn more: https://bit.ly/4bLYM3O [Video description: On-screen text reads, “33K+ Clinical Trial Participants; 147 Active Clinical Trial Studies; 6 Therapeutic Areas; One Big Thank You.”]
Páginas asociadas
Páginas similares
Acciones
ABBV
NYSE
20 minutos de retraso
161,24 USD
4,93 (3,154 %)
- Apertura
- 156,65
- Mínimo
- 156,2
- Máximo
- 161,64
Datos de Refinitiv
Consulta más información enFinanciación
Última ronda
Deuda tras OPV15.000.000.000,00 USD